Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance
about
The ABCs of Candida albicans Multidrug Transporter Cdr1Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulenceThe transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicansZinc finger transcription factors displaced SREBP proteins as the major Sterol regulators during Saccharomycotina evolutionXenobiotic efflux in bacteria and fungi: a genomics updateRegulation of hypoxia adaptation: an overlooked virulence attribute of pathogenic fungi?Genetic Basis of Antifungal Drug ResistanceModeling the transcriptional regulatory network that controls the early hypoxic response in Candida albicansAn A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicansUPC2 is universally essential for azole antifungal resistance in Candida albicans.UPC2A is required for high-level azole antifungal resistance in Candida glabrata.Prediction of phenotype-associated genes via a cellular network approach: a Candida albicans infection case studyInhibition of Candida albicans by Fluvastatin Is Dependent on pH.Disruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by FluconazoleRegulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.Differential requirement of the transcription factor Mcm1 for activation of the Candida albicans multidrug efflux pump MDR1 by its regulators Mrr1 and Cap1.The Hog1 mitogen-activated protein kinase mediates a hypoxic response in Saccharomyces cerevisiae.Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans.Using SCOPE to identify potential regulatory motifs in coregulated genes.In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2.Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stressGain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.Genome-wide mapping of the coactivator Ada2p yields insight into the functional roles of SAGA/ADA complex in Candida albicansIdentification of the Candida albicans Cap1p regulon.Role of Ndt80p in sterol metabolism regulation and azole resistance in Candida albicans.Coordinate control of lipid composition and drug transport activities is required for normal multidrug resistance in fungi.Novel antifungal drug discovery based on targeting pathways regulating the fungus-conserved Upc2 transcription factorDistinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulenceCandida albicans triggers NLRP3-mediated pyroptosis in macrophages.Transcription factor CCG-8 as a new regulator in the adaptation to antifungal azole stress.The global regulator Ncb2 escapes from the core promoter and impacts transcription in response to drug stress in Candida albicans.Medically important fungi respond to azole drugs: an update.Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.From Lipid Homeostasis to Differentiation: Old and New Functions of the Zinc Cluster Proteins Ecm22, Upc2, Sut1 and Sut2.Mechanism of de novo branched-chain amino acid synthesis as an alternative electron sink in hypoxic Aspergillus nidulans cellsAntifungal resistance and new strategies to control fungal infections.Mechanisms Underlying the Delayed Activation of the Cap1 Transcription Factor in Candida albicans following Combinatorial Oxidative and Cationic Stress Important for Phagocytic Potency.Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
P2860
Q26786747-DC1393B4-67AA-4171-AE99-6DB17C053D19Q28472787-D950E5DC-3CBE-4157-84B3-77D28CCCF36CQ28477254-A439CDEF-9B0F-47A0-8453-889BDAAAA8F8Q28538769-DA7810B7-7B21-40DC-B237-FFD6F429D0EFQ28834633-05B0FFBF-AE06-45FC-96DD-762DE682C281Q30377415-88671AAC-5465-4E4C-A078-9B2660E717CFQ30434904-59F90470-C232-49AC-8D9C-C45C16BCDFBDQ30580906-18F26505-9363-4E5D-8921-6EEA243AFD86Q33559158-0C3E11D0-3C49-4FD2-9477-8FA1A4243703Q34057076-507470CA-C846-4626-ADEF-ECE369191F5EQ34058180-3D8FFE1F-2CCB-4A6D-81F8-B4077D7894F3Q34235644-6A548BB5-B1F9-4BC5-B3FB-7F38118D5F8EQ34423788-8B43D690-CC09-4023-8346-87370A2D7909Q34596791-9016B7F9-C3B9-4922-9F76-891DBD13CFA3Q34932227-E1789721-3266-4401-A18D-D0EB630D56E3Q34932972-E6BDD828-3229-4C2A-A589-D71EF272C56CQ35065482-267DD46E-B444-4358-826D-4739D84CC7ADQ35221728-D4A2FC84-9663-4FD8-AEF7-92633E4F4E91Q35392313-32C928DC-D969-4E76-A609-54C9D38906FBQ35666568-8EA5662D-A0EB-438F-9DA9-556B4002F0AAQ35960980-3F046076-593B-4984-95DB-F2B708FF9708Q36362353-4004A0DA-2203-44FE-BBE4-6E47FB44A432Q36746995-0A502FE7-546E-43C0-9BA5-FE5201236E02Q37175383-D3F97B47-DA14-4F9A-9835-216478CFB804Q37232388-FF934678-0778-42C3-9317-15E6577452F3Q37301928-AA628DA0-C9A1-4356-9FED-AD53C1185899Q37371189-DA2C03A2-5C7F-4D81-9BFE-6E41F27392B9Q37544379-9D2B6868-7853-46C6-9E37-9DFD364B0DF6Q37545098-44629857-C910-4DD1-B9B7-363DFF3BA1FCQ37545146-C130B4E4-C28F-4811-84AD-CAF04D6C3130Q37643592-BA39545C-5DEE-4EB8-8FA6-D63F32D43A73Q37739596-DB9F3EAA-8883-4EDB-B3F1-04A0B75D439EQ38559208-DA57E30D-2004-416E-B631-07908BF3F106Q38627814-E1F09B5E-78DD-4F88-87A0-1B98CC814990Q38752384-894C9AEC-347F-4D7A-9B84-093A618D6DB5Q39221493-16A1DBE9-DB7D-4007-869D-8D5807BE2D5CQ39410850-0EC25BD8-D592-4E30-91BC-E9B8995C3D3FQ39751373-530F2D08-404E-4F23-976E-587D8A7234F1Q39772640-5DB49112-7CF5-45C8-8FF1-B34F5167D274Q40166236-978CC365-9EEA-41D3-A2F9-BC4C806C1F97
P2860
Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Genomewide location analysis o ...... lism and azole drug resistance
@en
type
label
Genomewide location analysis o ...... lism and azole drug resistance
@en
prefLabel
Genomewide location analysis o ...... lism and azole drug resistance
@en
P2093
P2860
P356
P1433
P1476
Genomewide location analysis o ...... lism and azole drug resistance
@en
P2093
François Robert
Martine Raymond
Osman Zin Al-Abdin
Perrine Bomme
Saloua Saidane
Sandra Weber
Simon Drouin
Sébastien Lemieux
Xavier De Deken
P2860
P304
P356
10.1128/EC.00070-08
P50
P577
2008-04-04T00:00:00Z